Abstract:The past 25 years have seen enormous progress in uncovering the receptors and signaling mechanisms on T-cells that activate their various effecter functions. Until the late 1980s, most studies on T-cells had focused on the influx of calcium and the levels of cAMP/GMP in T-cells. My laboratory then uncovered the interaction of CD4 and CD8 co-receptors with the protein-tyrosine kinase p56 lck which are now widely accepted as the initiators of the tyrosine phosphorylation cascade leading to T-cell activation. The finding explained how immune recognition receptors expressed by many immune cells, which lack intrinsic catalytic activity, can transduce activation signals via non-covalent association with non-receptor tyrosine kinases. The discovery also established the concept that a protein tyrosine phosphorylation cascade operated in T-cells. In this vein, we and others then showed that the CD4- and CD8-p56 lck complexes phosphorylate the TCR complexes which led to the identification of other protein-tyrosine kinases such as ZAP-70 and an array of substrates that are now central to studies in T-cell immunity. Other receptors such as B-cell receptor, Fc receptors and others were also subsequently found to use src kinases to control cell growth. In T-cells, p56 lck driven phosphorylation targets include co-receptors such as CD28 and CTLA-4 and immune cell-specific adaptor proteins such as LAT and SLP-76 which act to integrate signals proximal to surface receptors. CD4/CD8-p56 lck regulated events in T-cells include intracellular calcium mobilization, integrin activation and the induction of transcription factors for gene expression. Lastly, the identification of the targets of p56 lck in the TCR and CD28 provided the framework for the development of chimeric antigen receptor (CAR) therapy in the treatment of cancer. In this review, I outline a history of the development of events that led to the development of the “TCR signaling paradigm” and its implications to immunology and immunotherapy.

Cooperative Interaction of Nck and Lck Orchestrates Optimal TCR Signaling

Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

Unique roles of co-receptor-bound LCK in helper and cytotoxic T cells

Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT

The Activity and Stability of p56Lck and TCR Signaling Do Not Depend on the Co-Chaperone Cdc37

Selected signalling proteins recruited to the T-cell receptor-CD3 complex

CD28 Shapes T Cell Receptor Signaling by Regulating ZAP70 Activation and Lck Dynamics

NF‐κB is Crucial in Proximal T‐cell Signaling for Calcium Influx and NFAT Activation

Predicting protein interactions of the kinase Lck critical to T cell modulation

Essential role of the T cell–specific adapter protein in the activation of LCK in peripheral T cells

Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Regulation of Protein Kinase Cθ Function During T Cell Activation by Lck-mediated Tyrosine Phosphorylation

Coreceptors and TCR Signaling – the Strong and the Weak of It

TAOK3 Regulates Canonical TCR Signaling by Preventing Early SHP-1–Mediated Inactivation of LCK

CD146 bound to LCK promotes T cell receptor signaling and antitumor immune responses in mice

Biophysical basis underlying dynamic Lck activation visualized by ZapLck FRET biosensor.

Reciprocal TCR-CD3 and CD4 Engagement of a Nucleating pMHCII Stabilizes a Functional Receptor Macrocomplex

Beyond TCR Signaling: Emerging Functions of Lck in Cancer and Immunotherapy

How the Discovery of the CD4/CD8-p56lck Complexes Changed Immunology and Immunotherapy